Phase 2 Muscular Dystrophy Trial, By Invitation

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You must have already taken part in the related "parent" clinical trial called SAT-3247-CL-101.
• Your steroid medication dose (if you take one) must have stayed the same since the parent trial, or you must not be taking steroids at all.
• Any other regular medicines, supplements, or over-the-counter products you take must have stayed at the same doses since the parent trial.
• You must be able to understand what the trial involves and any risks that come with taking part.
• You must be able to communicate clearly with the trial team and follow all trial requirements, including attending visits, doing tests, filling in questionnaires, and wearing any devices provided.
• You (and a parent or legal guardian if needed) must be willing to sign a consent form after being fully informed about the trial.
• If you are sexually active, you must agree to follow the birth control and sperm donation rules set out in the trial plan.

Who may not be able to join:

• You have a serious current or ongoing health condition (other than Duchenne Muscular Dystrophy) that could make participation unsafe or affect the results.
• You are expected to need spine surgery or a planned hospital stay for a non-emergency health reason within the next 12 months.
• You currently have stomach or gut symptoms (such as nausea, vomiting, diarrhoea, or heartburn), an active infection (such as flu), or a significant infection or inflammation at the time of your screening appointment.
• You have serious behavioural or thinking difficulties that would prevent you from taking part, in the opinion of the trial doctor.
• You have developed heart muscle problems with symptoms since finishing the parent trial.
• You are unable to swallow tablets (though tablets may be split or crushed and mixed into food or a flavoured drink, so confirm with the trial site if this applies to you).
• You have taken part in another clinical trial or received another experimental treatment since finishing the parent trial (confirm with trial site if you have used deflazacort or vamorolone, as these may be exceptions depending on your location).
• The trial team believes you may not be able or willing to follow the trial requirements.
• You are an employee, contractor, or consultant of the company running the trial, the research organisation supporting it, or the trial site — or you are a close relative of someone who is.

Important: Always verify eligibility with the trial site directly before applying.